Results 201 to 210 of about 61,690 (282)

Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial

open access: yesLancet, The, 2015
BACKGROUND Cardiopulmonary bypass initiates a systemic inflammatory response syndrome that is associated with postoperative morbidity and mortality. Steroids suppress inflammatory responses and might improve outcomes in patients at high risk of morbidity
Richard P Whitlock   +2 more
exaly   +2 more sources

Cardiopulmonary Bypass

AJN, American Journal of Nursing, 1974
None of the extracorporeal perfusion systems equals the perfection of the human heart and lung. Therefore, physiological changes occur during and after surgery which may affect the patient's postoperative course and treatment. There are significant changes in the patient's clotting mechanism.
M L, Long   +2 more
openaire   +4 more sources

Managing the coagulopathy associated with cardiopulmonary bypass

Journal of Thrombosis and Haemostasis, 2020
Cardiopulmonary bypass (CPB) has allowed for significant surgical advancements, but accompanying risks can be significant and must be expertly managed. One of the foremost risks is coagulopathic bleeding. Increasing levels of bleeding in cardiac surgical
J. Bartoszko, K. Karkouti
semanticscholar   +1 more source

Cardiopulmonary bypass

Current Opinion in Cardiology, 1991
There has been a recent renewed interest in certain aspects of cardiopulmonary bypass employing extracorporeal circulation. Several areas have received special attention. Among these is the institution of extracorporeal circulation using a percutaneous technique for circulatory assistance during high-risk percutaneous transluminal coronary ...
V A, Ferraris   +3 more
openaire   +4 more sources

Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation

open access: yesJournal of Thoracic and Cardiovascular Surgery, 2015
Tiago N Machuca   +2 more
exaly   +2 more sources

Inflammatory Response and Endothelial Dysfunction Following Cardiopulmonary Bypass: Pathophysiology and Pharmacological Targets.

Recent Patents on Inflammation & Allergy Drug Discovery, 2019
BACKGROUND Endothelial injury occurring during cardiopulmonary bypass is a major contributing factor in the development of organ dysfunction, which leads to many of the postoperative complications occurring during cardiac surgery.
Omar Giacinto   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy